The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
from badhak if it is a prothrombotic protein there's plenty of evidence suggesting it is by the way with arterial not so much venous thrombosis many people have dismissed LP little a is being linked to venous thrombosis I don't know the source but if you talk to Shimon and he will tell you oh it's interesting I stand corrected because I think I was probably quoting some old data when I said that the VTE hazard ratio is about two yeah but it's just weak sort of data
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.